Applied Health Economics Team


Prof Steve Davies
Founding Director

Prof Davies is a Consultant Endocrinologist at the University Hospital Wales. He has an established reputation in medical education particularly online learning, having been the founder of and having set up other diploma courses. He has also been involved in establishing training courses for weight management in community pharmacy. His clinical interests include hypogonadism, growth hormone deficiency and obesity. He has published over 100 peer reviewed publications and his research interests include the application of novel technologies in delivering medical education.


Dr Ruth Davis
Academic Director

After completing a nursing degree in Cardiff, Dr Davis worked in Torbay Hospital, Torquay, before moving to Southampton where she set up the diabetes nursing service. While there Dr Davis undertook diabetes research, co-founded the Wessex Diabetes Nurses group and served on the RCN Diabetes Nursing Forum. She returned to Cardiff to teach in the College of Medicine. Following a strategic review of services Dr Davis became Diabetes Care Coordinator for Bro Taf Health Authority, managing diabetes specialist nurses, establishing Local Diabetes Service Advisory Groups, advising government on policy, developing clinical guidelines, establishing the all Wales retinal screening programme and setting up a Diabetes Centre. She moved to the University of Glamorgan (now University of South Wales) and developed a variety of courses, teaching and researching in diabetes and managing the School of Care Sciences. Dr Davis now works freelance on a variety of projects maintaining my links with diabetes and the University.


Dr Karl New
Course Lead

Dr New is currently working for the University of South Wales and has the responsibility for overseeing Exercise Physiology and Biochemistry. His first degree is in Applied Sport Science from the University of Glamorgan and he has a teaching qualification in Physical Education from UWIC alongside a Doctorate in Exercise Physiology also from the University of Glamorgan. Dr New has a keen interest in online teaching and delivering content/assessing through the digital platform.

No Image Available

Dr Richard Greville
Faculty Member

A graduate of Cardiff University, Richard was appointed as Director, ABPI Cymru Wales in May 2003 after serving an apprenticeship of over 15 years within the pharmaceutical industry. Since then he has enjoyed the challenges of raising the understanding and profile of the pharmaceutical industry with a range of stakeholders, including professional bodies, Welsh Assembly Members and the NHS in Wales. In 2007, Richard added the role of Director of ABPI Northern Ireland to his responsibilities. Richard is Acting Chair of the NHS-Industry Forum, a sub-group of the All Wales Medicines Strategy Group (AWMSG), working alongside colleagues from industry and the NHS in Wales. He is also a member of the Advisory Boards of the Wales Office for Research and Development in Health, and Social Care (WORD), Health Informatics Research Unit (HIRU) and the Wales Cancer Bank.


Peter Conway
Co-Course Director

Pete Conway has 20 years’ experience as both a Health Economist and Market Access Lead in the pharmaceutical industry, working across many therapeutic areas. Initially trained as a hospital/clinical pharmacist in the UK, he further developed his experience working as a Payer Pharmacist in charge of formulary control in a large tertiary care hospital.

He then trained and qualified as a Health Economist at Glaxo Welcome working in oncology and diabetes working on the first NICE submission in 1998/9. Pete has led nearly 50 health technology appraisal submissions across more than 10 brands for Wyeth Pharmaceuticals UK. As Head of EU Market Access at Wyeth, he focused on the internationalization of ENBREL, PREVENAR and EFEXOR guiding them through multiple pricing and reimbursement processes. Within inflammation, he lead the reimbursement of ENBREL in RA, psoriasis, psoriatic arthritis, and ankylosing spondylitis, and is an author on several papers relating to economics in RA, including the first economic model for biologics in RA.

More recently, he was Executive Director, Head of UK Market Access at Grunenthal UK covering health outcomes, market access marketing, government affairs and field-based payer interface specializing in the area of pain, focusing on PALEXIA and then Head of Global Market Access for Norgine Ltd.

Currently, he is working as Managing Director of ELM Market Access, supporting a number of pharmaceutical companies in HEOR services

Course Tutors

Early Bird Discount Deadline